Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Lancet, Mar 28 2025, S0140-6736(25)00449-0 | https://doi.org/10.1016/S0140-6736(25)00449-0
Intravascular Imaging and Angiography Guidance in Complex Percutaneous Coronary Intervention Among Patients With Diabetes: A Secondary Analysis of a Randomized Clinical Trial
JAMA Netw. Open, Jun 03 2024, 7 (6) | https://doi.org/10.1001/jamanetworkopen.2024.17613
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial
JAMA-J. Am. Med. Assoc., June 25, 2019, 321(24):2428-2437 | doi:10.1001/jama.2019.8146